Гиппократ не рад. Путеводитель в мире медицинских исследований - Ирина Игоревна Бодэ
Шрифт:
Интервал:
Закладка:
20. Vargesson, N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res. C. Embryo Today 105, 140–56 (2015).
21. Stephens, T. D., Bunde, C. J. & Fillmore, B. J. Mechanism of action in thalidomide teratogenesis. Biochem. Pharmacol. 59, 1489–99 (2000).
22. Merker, H. J., Heger, W., Sames, K., Stürje, H. & Neubert, D. Embryotoxic effects of thalidomide-derivatives in the non-human primate Callithrix jacchus. I. Effects of 3-(1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-dioxopiperidine (EM12) on skeletal development. Arch. Toxicol. 61, 165–79 (1988).
23. Latif, T., Chauhan, N., Khan, R., Moran, A. & Usmani, S. Z. Thalidomide and its analogues in the treatment of Multiple Myeloma. Exp. Hematol. Oncol. 1, 27 (2012).
24. Rehman, W., Arfons, L. M. & Lazarus, H. M. The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development. Ther. Adv. Hematol. 2, 291–308 (2011).
25. Ecklund, E. H., Johnson, D. R., Scheitle, C. P., Matthews, K. R. W. & Lewis, S. W. Religion among Scientists in International Context. Socius Sociol. Res. a Dyn. World 2, 237802311666435 (2016).
26. Scientists and Belief | Pew Research Center. Available at: http://www.pewforum.org/2009/11/05/scientists-and-belief/#fn-12952-1. (Accessed: 10th November 2018)
27. Принципы надлежащей лабораторной практики. (Стандартинформ, 2015).
28. ГОСТ Р 52249-2009 Правила производства и контроля качества лекарственных средств. Available at: http://www.vashdom.ru/gost/52249-2009/. (Accessed: 1st November 2018)
29. Willingham, E. Of lice and men: An itchy history. Scientific American (2011).
30. Han, H. et al. Association of genetic polymorphisms in ADH and ALDH2 with risk of coronary artery disease and myocardial infarction: A meta-analysis. Gene 526, 134–141 (2013).
31. WHO | Breast cancer: prevention and control. WHO (2016).
32. Широкова И. & Прожерина Ю. Рак молочной железы: взгляд экспертов. Ремедиум. Журнал о российском рынке лекарств и медицинской технике (2016).
33. Демография::Федеральная служба государственной статистики. Available at: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/#. (Accessed: 11th November 2019)
34. Клинические рекомендации РООМ. Available at: http://breastcancersociety.ru/rek/view/201. (Accessed: 11th November 2018)
35. Oeffinger, K. C. et al. Breast Cancer Screening for Women at Average Risk. JAMA 314, 1599 (2015).
36. Breast Cancer in Young Women. Available at: https://www.webmd.com/breast-cancer/breast-cancer-young-women#1. (Accessed: 11th November 2018)
37. Ferzoco, R. M. & Ruddy, K. J. The Epidemiology of Male Breast Cancer. Curr. Oncol. Rep. 18, 1 (2016).
38. Controversies in Mammography Screening. Available at: https://www.medscape.com/viewarticle/430076. (Accessed: 11th November 2018)
39. Mammograms: Benefits and Risks. Available at: https://www.breastcancer.org/symptoms/testing/types/mammograms/benefits_risks. (Accessed: 11th November 2018)
40. Bashir, M. N. Epidemiology of Prostate Cancer. Asian Pac. J. Cancer Prev. 16, 5137–41 (2015).
41. Tsodikov, A. et al. Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. Ann. Intern. Med. 167, 449 (2017).
42. Prostate Cancer Screening Guidelines | Memorial Sloan Kettering Cancer Center. Available at: https://www.mskcc.org/cancer-care/types/prostate/screening/screening-guidelines-prostate. (Accessed: 12th November 2018)
43. Общероссийский союз общественных объединений. Ассоциация онкологов России. Клинические рекомендации по диагностике и лечению рака предстательной железы. (2014).
44. Российское общество урологов, Ассоциация онкологов России & Российское общество онкоурологов. Клинические рекомендации: рак предстательной железы. (2016).
45. Ilic, D., Neuberger, M. M., Djulbegovic, M. & Dahm, P. Screening for prostate cancer. Cochrane Database Syst. Rev. (2013). doi:10.1002/14651858.CD004720.pub3
46. Rothwell, P. M. et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376, 1741–1750 (2010).
47. Chen, J. et al. Identification of a novel TIF-IA – NF-κB nucleolar stress response pathway. Nucleic Acids Res. 46, 6188–6205 (2018).
48. Hudson, A. L. & Colvin, E. K. Transgenic Mouse Models of SV40-Induced Cancer. ILAR J. 57, 44–54 (2016).
49. Council, I. of M. and N. R. Use of Laboratory Animals in Biomedical and Behavioral Research. (National Academies Press, 1988). doi:10.17226/1098
50. Malhi, G. S., Tanious, M., Das, P., Coulston, C. M. & Berk, M. Potential Mechanisms of Action of Lithium in Bipolar Disorder. CNS Drugs 27, 135–153 (2013).
51. Lithium’s Mechanism of Action – A Focus on Neuroprotection. 23, (2017).
52. Lithium’s Hypothetical Mechanism of Action. Available at: https://www.youtube.com/watch?v=iNH0GdldxYs. (Accessed: 5th January 2019)
53. Shorter, E. The history of lithium therapy. Bipolar Disord. 11 Suppl 2, 4–9 (2009).
54. Nikiphorou, E., Uksila, J. & Sokka, T. A cross-sectional study of vitamin D levels in a large cohort of patients with rheumatic diseases. Clin. Rheumatol. 37, 803–810 (2018).
55. Ilic, M. & Ilic, I. Epidemiology of pancreatic cancer. World J. Gastroenterol. 22, 9694–9705 (2016).
56. Streicher, S. A., Yu, H., Lu, L., Kidd, M. S. & Risch, H. A. Case-Control Study of Aspirin Use and Risk of Pancreatic Cancer. Cancer Epidemiol. Biomarkers Prev. 23, 1254–1263 (2014).
57. Framingham Heart Study. Available at: https://www.framinghamheartstudy.org/. (Accessed: 10th January 2019)
58. Framingham Risk Score for Hard Coronary Heart Disease. doi:10.1056/NEJM199006073222304
59. SCORE Risk Charts. Available at: https://www.escardio.org/Education/Practice-Tools/CVD-prevention-toolbox/SCORE-Risk-Charts. (Accessed: 18th December 2017)
60. NHS3 – Looking forward, connecting to the past. Available at: http://nhs2survey.org/wordpress/. (Accessed: 10th January 2019)
61. Lynch, J. J., Frederick Fregin, G., Mackie, J. B. & Monroe, R. R. Heart Rate Changes in the Horse to Human Contact. Psychophysiology 11, 472–478 (1974).
62. Keller, A., Akintola, T. & Colloca, L. Placebo Analgesia in Rodents: Current and Future Research.
